Molnupiravir in COVID-19: A systematic review of literature

AK Singh, A Singh, R Singh, A Misra - Diabetes & Metabolic Syndrome …, 2021 - Elsevier
Background and aims Molnupiravir is a newer oral antiviral drug that has recently been
tested in COVID-19. We aim to conduct a systematic review of literature to find out the …
被引用次数：255 相关文章

Molnupiravir in COVID-19: A systematic review of literature

AK Singh, A Singh, R Singh… - Diabetes & metabolic …, 2021 - pubmed.ncbi.nlm.nih.gov
Background and aims Molnupiravir is a newer oral antiviral drug that has recently been
tested in COVID-19. We aim to conduct a systematic review of literature to find out the …

Molnupiravir in COVID-19: A systematic review of literature.

AK Singh, A Singh, R Singh, A Misra - Diabetes & Metabolic …, 2021 - europepmc.org
Methods We systematically searched the electronic database of PubMed, MedRxiv and
Google Scholar from inception until October 15, 2021, using MeSH keywords. Ongoing trials …

[引用][C] Molnupiravir in COVID-19: A systematic review of literature

AK Singh, A Singh, R Singh, A Misra - Diabetes & Metabolic Syndrome …, 2021 - cir.nii.ac.jp
Molnupiravir in COVID-19: A systematic review of literature | CiNii Research CiNii 国立
情報学研究所 学術情報ナビゲータ[サイニィ] 論文・データをさがす 大学図書館の本をさがす 日本の …
[HTML] nih.gov

[HTML][HTML] Molnupiravir in COVID-19: A systematic review of literature

AK Singh, A Singh, R Singh, A Misra - Diabetes & Metabolic …, 2021 - ncbi.nlm.nih.gov
Methods We systematically searched the electronic database of PubMed, MedRxiv and
Google Scholar from inception until October 15, 2021, using MeSH keywords. Ongoing trials …
[PDF] researchgate.net

[PDF][PDF] Molnupiravir in COVID-19: A systematic review of literature

AK Singh, A Singh, R Singh, A Misra - Diabetes & Metabolic …, 2021 - researchgate.net
abstract Background and aims: Molnupiravir is a newer oral antiviral drug that has recently
been tested in COVID-19. We aim to conduct a systematic review of literature to find out the …